Related Experiment Video
Updated: Jul 14, 2026
05:42
Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
Published on: October 25, 2024
Treatment guidelines in ovarian cancer
A Poveda Velasco1, A Casado Herráez, A Cervantes Ruipérez
1Servicio de Oncología Médica, Fundación Instituto Valenciano de Oncología, Valencia, Spain. apveda@fivo.org
Summary
New guidelines for epithelial ovarian cancer treatment are established, emphasizing early detection and surgical strategies. These recommendations aim to improve the low survival rate for this prevalent gynecological cancer.
Area of Science:
- Gynecologic Oncology
- Clinical Practice Guidelines
Background:
- Epithelial ovarian cancer is a leading cause of cancer death in women in Western countries.
- Low survival rates (30% at 5 years) are attributed to late diagnosis and suboptimal surgical management.
Purpose of the Study:
- To establish evidence-based guidelines for the treatment of epithelial ovarian cancer in Spanish Castilian.
- To update and adapt the 2005 International Consensus guidelines for current clinical practice.
Main Methods:
- Review and synthesis of the 2005 International Consensus on ovarian cancer.
- Development of recommendations for early detection, surgical staging, and therapeutic strategies.
- Inclusion of information on molecularly targeted therapies and clinical trial methodologies.
Main Results:
- Guidelines emphasize the critical role of early diagnosis and appropriate surgical procedures.
- Recommended treatments include cytoreductive surgery and platinum-based chemotherapy for primary and recurrent disease.
- Recent advancements in molecularly targeted treatments are presented.
Conclusions:
- Adherence to these guidelines can improve patient outcomes for epithelial ovarian cancer.
- Cooperation in clinical trials is essential for validating new therapeutic approaches.
- Early detection and optimized surgical intervention are paramount for improving survival rates.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...